questionsmedicales.fr
Qualité, accès, évaluation des soins de santé
Prestations des soins de santé
Attitude envers la santé
Adhésion et observance thérapeutiques
Acceptation des soins par les patients
Observance par le patient
Adhésion au traitement médicamenteux
Adhésion au traitement médicamenteux : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Adhésion au traitement médicamenteux : Questions médicales les plus fréquentes",
"headline": "Adhésion au traitement médicamenteux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Adhésion au traitement médicamenteux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-29",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Adhésion au traitement médicamenteux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Observance par le patient",
"url": "https://questionsmedicales.fr/mesh/D010349",
"about": {
"@type": "MedicalCondition",
"name": "Observance par le patient",
"code": {
"@type": "MedicalCode",
"code": "D010349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.300.150.800.500.600"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie sous observation directe",
"alternateName": "Directly Observed Therapy",
"url": "https://questionsmedicales.fr/mesh/D023801",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie sous observation directe",
"code": {
"@type": "MedicalCode",
"code": "D023801",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.300.150.800.500.600.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Adhésion au traitement médicamenteux",
"alternateName": "Medication Adherence",
"code": {
"@type": "MedicalCode",
"code": "D055118",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paula Anne Newman-Casey",
"url": "https://questionsmedicales.fr/author/Paula%20Anne%20Newman-Casey",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan. Electronic address: panewman@umich.edu."
}
},
{
"@type": "Person",
"name": "Michal Shani",
"url": "https://questionsmedicales.fr/author/Michal%20Shani",
"affiliation": {
"@type": "Organization",
"name": "Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel."
}
},
{
"@type": "Person",
"name": "Alex Lustman",
"url": "https://questionsmedicales.fr/author/Alex%20Lustman",
"affiliation": {
"@type": "Organization",
"name": "Department of Family Medicine, Central District, Clalit Health Services, Tel Aviv, Israel."
}
},
{
"@type": "Person",
"name": "Tino Prell",
"url": "https://questionsmedicales.fr/author/Tino%20Prell",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Jena University Hospital, Jena, Germany."
}
},
{
"@type": "Person",
"name": "Julian Grosskreutz",
"url": "https://questionsmedicales.fr/author/Julian%20Grosskreutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Jena University Hospital, Jena, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pontine tegmental cap dysplasia: the role of diffusion tensor imaging.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37993144",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-253556"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diffusion tensor imaging for the differential diagnosis of Parkinsonism by machine learning.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35671948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bj.2022.05.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Analysis of the Apparent Diffusion Coefficient and Diffusion Tensor Imaging in the Diagnosis of Prostate Cancer.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/39068573",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2024.25.7.2397"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of diffusion tensor imaging in stenotic and non-stenotic spinal canal.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/37891147",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmir.2023.09.022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diffusion tensor imaging metrics associated with future disability in multiple sclerosis.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36864113",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-30502-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Prestations des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D003695"
},
{
"@type": "ListItem",
"position": 4,
"name": "Attitude envers la santé",
"item": "https://questionsmedicales.fr/mesh/D001294"
},
{
"@type": "ListItem",
"position": 5,
"name": "Adhésion et observance thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D000074822"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acceptation des soins par les patients",
"item": "https://questionsmedicales.fr/mesh/D010342"
},
{
"@type": "ListItem",
"position": 7,
"name": "Observance par le patient",
"item": "https://questionsmedicales.fr/mesh/D010349"
},
{
"@type": "ListItem",
"position": 8,
"name": "Adhésion au traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D055118"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Adhésion au traitement médicamenteux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Adhésion au traitement médicamenteux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Adhésion au traitement médicamenteux",
"description": "Comment évaluer l'adhésion au traitement ?\nQuels tests peuvent indiquer une mauvaise adhésion ?\nQuels signes cliniques montrent une non-adhésion ?\nComment les professionnels évaluent-ils l'adhésion ?\nQuelles sont les méthodes d'auto-évaluation ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Adhésion au traitement médicamenteux",
"description": "Quels symptômes indiquent une mauvaise adhésion ?\nComment la non-adhésion affecte-t-elle les symptômes ?\nLes effets secondaires influencent-ils l'adhésion ?\nQuels symptômes psychologiques peuvent apparaître ?\nLes symptômes de sevrage affectent-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Adhésion au traitement médicamenteux",
"description": "Comment prévenir la non-adhésion au traitement ?\nQuel rôle joue la communication médecin-patient ?\nLes rappels de médicaments sont-ils efficaces ?\nComment impliquer la famille dans l'adhésion ?\nLes groupes de soutien aident-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Adhésion au traitement médicamenteux",
"description": "Quels traitements améliorent l'adhésion ?\nComment les professionnels aident-ils à l'adhésion ?\nLes thérapies combinées influencent-elles l'adhésion ?\nQuel rôle jouent les applications de santé ?\nLes programmes d'éducation améliorent-ils l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Adhésion au traitement médicamenteux",
"description": "Quelles complications résultent d'une mauvaise adhésion ?\nComment la non-adhésion affecte-t-elle la maladie ?\nLes complications psychologiques sont-elles fréquentes ?\nLa résistance aux médicaments est-elle liée à l'adhésion ?\nLes complications financières influencent-elles l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Adhésion au traitement médicamenteux",
"description": "Quels facteurs augmentent le risque de non-adhésion ?\nLe niveau d'éducation influence-t-il l'adhésion ?\nLes problèmes de santé mentale affectent-ils l'adhésion ?\nLe soutien social joue-t-il un rôle ?\nLes croyances culturelles influencent-elles l'adhésion ?",
"url": "https://questionsmedicales.fr/mesh/D055118?mesh_terms=Diffusion+Tensor+Imaging&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'adhésion au traitement ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'adhésion peut être évaluée par des questionnaires, des entretiens et des mesures de médicaments."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent indiquer une mauvaise adhésion ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de niveaux sanguins de médicaments peuvent révéler une non-adhésion."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques montrent une non-adhésion ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exacerbations de la maladie ou des hospitalisations fréquentes peuvent indiquer une non-adhésion."
}
},
{
"@type": "Question",
"name": "Comment les professionnels évaluent-ils l'adhésion ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils utilisent des outils comme les journaux de médication et les entretiens avec les patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes d'auto-évaluation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent utiliser des applications ou des journaux pour suivre leur prise de médicaments."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une mauvaise adhésion ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes persistants ou aggravés peuvent signaler une mauvaise adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Comment la non-adhésion affecte-t-elle les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une aggravation des symptômes et une détérioration de la santé globale."
}
},
{
"@type": "Question",
"name": "Les effets secondaires influencent-ils l'adhésion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent décourager les patients de suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes psychologiques peuvent apparaître ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété et la dépression peuvent résulter d'une mauvaise adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Les symptômes de sevrage affectent-ils l'adhésion ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes de sevrage peuvent inciter les patients à ne pas suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir la non-adhésion au traitement ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, le soutien psychologique et des suivis réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la communication médecin-patient ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne communication favorise la compréhension et l'adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Les rappels de médicaments sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rappels par SMS ou applications augmentent l'adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Comment impliquer la famille dans l'adhésion ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La famille peut soutenir le patient en l'aidant à suivre son traitement et à gérer les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien aident-ils l'adhésion ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un environnement motivant et des conseils pratiques."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent l'adhésion ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements simplifiés et les médicaments à dose unique par jour favorisent l'adhésion."
}
},
{
"@type": "Question",
"name": "Comment les professionnels aident-ils à l'adhésion ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils fournissent des conseils, des rappels et des outils de suivi pour améliorer l'adhésion."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées influencent-elles l'adhésion ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies combinées peuvent compliquer l'adhésion si elles ne sont pas bien gérées."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les applications de santé ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les applications aident à rappeler aux patients de prendre leurs médicaments et à suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Les programmes d'éducation améliorent-ils l'adhésion ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation des patients sur leur maladie et leur traitement favorise l'adhésion."
}
},
{
"@type": "Question",
"name": "Quelles complications résultent d'une mauvaise adhésion ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des hospitalisations, des rechutes et des complications graves."
}
},
{
"@type": "Question",
"name": "Comment la non-adhésion affecte-t-elle la maladie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une progression de la maladie et une réponse moins efficace au traitement."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la non-adhésion peut entraîner des troubles psychologiques comme l'anxiété."
}
},
{
"@type": "Question",
"name": "La résistance aux médicaments est-elle liée à l'adhésion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise adhésion peut contribuer à la résistance aux médicaments, surtout en infectiologie."
}
},
{
"@type": "Question",
"name": "Les complications financières influencent-elles l'adhésion ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les coûts des médicaments peuvent dissuader les patients de suivre leur traitement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de non-adhésion ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la complexité du traitement, les effets secondaires et le manque de soutien."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation influence-t-il l'adhésion ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible niveau d'éducation peut réduire la compréhension du traitement et l'adhésion."
}
},
{
"@type": "Question",
"name": "Les problèmes de santé mentale affectent-ils l'adhésion ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles mentaux peuvent diminuer la capacité d'un patient à suivre son traitement."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien social peut améliorer l'adhésion au traitement et la gestion de la maladie."
}
},
{
"@type": "Question",
"name": "Les croyances culturelles influencent-elles l'adhésion ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines croyances culturelles peuvent affecter la perception et l'adhésion au traitement."
}
}
]
}
]
}
Pontine tegmental cap dysplasia (PTCD) is a rare hindbrain malformation syndrome. Recurrent aspiration pneumonia is a major cause of death during a first year of life. We report the case of month-old ...
There are currently no specific tests for either idiopathic Parkinson's disease or Parkinson-plus syndromes. The study aimed to investigate the diagnostic performance of features extracted from the wh...
The retrospective data yielded 625 participants (average age: 61.4 ± 8.2, men/women: 313/312; healthy controls/idiopathic Parkinson's disease/multiple system atrophy/progressive supranuclear palsy: 21...
Diagnoses were accurate for distinguishing idiopathic Parkinson's disease from healthy control and Parkinson-plus syndromes (87.4 ± 2.1% and 82.5 ± 3.9%, respectively). Diagnostic F1 scores varied for...
Features extracted from diffusion tensor imaging of the whole brain can provide objective evidence for the diagnosis of healthy control, idiopathic Parkinson's disease, and Parkinson-plus syndromes wi...
The aim of this work was to demonstrate capabilities of diffusion tensor imaging as a diagnostic tool for prostate cancer in comparison with the apparent diffusion coefficient....
364 patients with suspected prostate cancer underwent multiparametric magnetic resonance imaging including diffusion tensor imaging....
The anatomical structure of the prostate obtained on T2-weighted imaging was compared with the apparent diffusion coefficient and diffusion tensor imaging maps. The rest of the gland (central and peri...
Diffusion tensor imaging has the potential to identify prostate cancer with high accuracy and specificity. The combination of standard magnetic resonance imaging and diffusion tensor imaging can signi...
Cervical Spondylotic Myelopathy (CSM) is a gradually escalating spinal cord disturbance set in motion by the degenerative narrowing of the vertebral canal. Routine MRI may fail to detect the subtle ea...
Sixty-four subjects who met the requirements of the inclusion criteria were incorporated into the investigation. All subjects underwent routine MRI sequences in addition to DTI of the cervical spine r...
A noteworthy difference (p<0.05) was seen in the FA parameter and ADC parameter values between the stenotic and non-stenotic groups, with the non-stenotic group having a higher mean FA and a lower ADC...
DTI parameters, namely FA and ADC, are sensitive to damage to the white matter and can be used to detect microstructural changes in the cord. However, standardization of the protocol is necessary when...
The relationship between brain diffusion microstructural changes and disability in multiple sclerosis (MS) remains poorly understood. We aimed to explore the predictive value of microstructural proper...
Quantifying the rotator cuff (RC) muscles' viscoelasticity could provide outcome relevant information in patients with RC tears. MR-elastography requires robust diffusion-tensor imaging (DTI) to accou...
To assess the repeatability of DTI parameters in the supraspinatus and infraspinatus muscles and to explore DTI tractography conformity with the muscles' anatomy....
Prospective....
Six healthy volunteers underwent three consecutive shoulder MRI sessions about 10 minutes apart....
3T/T1-vibe Dixon and Spin echo EPI DTI (12 gradient encoding directions, b-values 500 and 800 sec/mm...
Supraspinatus and infraspinatus muscles were segmented on the T1-vibe Dixon sequence. DTI image quality was assessed using a quantitative threshold based on the signal-to-noise ratio (SNR). The eigenv...
DTI parameters within-subject intersession repeatability was assessed with Bland-Altman analysis and the coefficient of variation (CV). Repeatability was considered good for CV < 10%....
The SNR between diffusion-weighted and non-diffusion-weighted images was greater than 3, which aligns with standards for estimating DTI parameters. The FA showed the lowest mean bias (-0.007; 95% conf...
DTI of the supraspinatus and infraspinatus muscles achieved an adequate SNR, allowing the measurement of the DTI metrics with good repeatability, and thus can be used for optimizing stiffness estimati...
2 TECHNICAL EFFICACY: Stage 2....
The caudate nucleus has been thought to be involved in the control of motor commands by the cerebrum, and recent studies suggest that it may play a role in the control of attachment behavior, cognitio...
Cardiac diffusion tensor imaging (DTI) is a noninvasive method for measuring the microstructure of the myocardium. However, its long scan time significantly hinders its wide application. In this study...
The prefrontal cortex (PFC) is a heterogenous structure that is highly susceptible to the effects of aging. Few studies have investigated age effects on the superficial white matter (WM) contained wit...
Diffusion tensor imaging (DTI) is an emerging technique for peripheral nerve imaging that can provide information about the microstructural organization and connectivity of these nerves and complement...